Cancer and venous thromboembolism
- 31 October 1996
- journal article
- review article
- Published by Elsevier BV in American Heart Journal
- Vol. 132 (4), 850-855
- https://doi.org/10.1016/s0002-8703(96)90321-x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Shortened hospitalization by means of adjusted-dose subcutaneous heparin for deep venous thrombosisAmerican Heart Journal, 1996
- The clinical value of tissue factor assaysBlood Coagulation & Fibrinolysis, 1995
- Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancerThe Lancet, 1994
- Prothrombin Fragment F 1 + 2 Plasma Concentrations in Patients with Gynecologic MalignanciesGynecologic Oncology, 1993
- Diagnosis and Treatment of Cancer-Related ThrombosisSeminars in Thrombosis and Hemostasis, 1992
- Factor IXi-antithrombin (IXiAT) and thrombin-antithrombin (TAT) complexes in lung cancer patientsAnnals of Hematology, 1992
- Identification and partial purification of a novel tumor-derived protein that induces tissue factor on cultured human endothelial cellsBiochemical and Biophysical Research Communications, 1989
- The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast CancerNew England Journal of Medicine, 1988
- Prophylaxis of postoperative leg vine thrombosis by low dose subcutaneous heparin or peroperative calf muscle stimulation: a controlled clinical trial.BMJ, 1975
- A STUDY OF PULMONARY EMBOLISM AND DEEP LEG VEIN THROMBOSIS AFTER MAJOR GYNAECOLOGICAL SURGERY USING LABELLED FIBRINOGEN‐PHLEBOGRAPHY AND LUNG SCANNINGBJOG: An International Journal of Obstetrics and Gynaecology, 1974